Mark Foote Dalton

Tudor Investment Corp. (TIC) is an independent, SEC-registered investment adviser and hedge fund manager headquartered in Stamford, Connecticut. The firm was founded in 1980 by Paul T. Jones, II. TIC provides discretionary investment advisory services to various hedge funds, private equity funds and managed accounts. Investors in these funds generally include high-net worth individuals and related entities, sovereign entities, pension funds, non-financial corporates, financial institutions, endowments and foundations, fund-of-fund vehicles and proprietary capital from current and former personnel.

Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY.

Kidder, Peabody & Co., Inc. provides security brokerage services. The private company is based in Buffalo, NY and has subsidiaries in Switzerland. The company was founded by Thomas W. Ostrander.

Sullivan & Cromwell LLP provides legal services. It specializes in the areas of corporate law, securities, corporate, litigation, mergers, real estate, pro bono, investment management and taxation. Their clients include industrial, commercial, financial, private funds, governmental, educational, charitable and cultural enterprises and entities. The company was founded by Algernon Sydney Sullivan and William Nelson Cromwell in 1879 and is headquartered in New York City, NY.

Tudor Riverbend Crossing Partners LP operates as a pooled investment fund. The company is headquartered in Greenwich, CT.

The Buoniconti Fund to Cure Paralysis, Inc. provides treatment for spinal cord and brain injuries. The company was founded by Nicholas A. Buoniconti and Barth A. Green in 1992 and is headquartered in Miami, FL.